Read More...
GBC’s Fry: Bioscience teamwork
Read More...
Entering the final week of the 2006 legislative session, we can report a number of successes on the GBC legislative agenda that have resulted. Unfortunately, as we anticipated, a number of our new proposals, although positively received, have not moved through the legislative cycle. The following is an overview of the status of GBC legislative priorities: Eminent Domain: The GBC strongly opposes any legislation that would inhibit the use of … Continue reading →
The Greater Baltimore Committee is urging state lawmakers to pass a newly proposed tax credit for businesses that locate at research parks affiliated with one of Maryland’s higher education institutions. Legislation that would create the tax credit, SB 739, was heard today by the Senate Budget and Taxation Committee. Sponsored by Senator Nathaniel J. McFadden, D-Baltimore City, the bill would award a state income tax credit to companies moving into … Continue reading →
Bioscience industry growth in Baltimore and Maryland is “beginning to percolate, and others elsewhere are noticing,” reports GBC president Donald C. Fry in the Daily Record’s annual TechLink special section that profiles the state of the region’s growing bioscience business sector. Published in the Daily Record’s February 24 edition, the section details the work of more than a dozen biotech companies in the region and the efforts of the GBC … Continue reading →
The Greater Baltimore Committee March 1 urged state lawmakers to increase the amount of tax credits available in Maryland for investment in research and development. The GBC also supported legislation that would increase the amount of tax credits individuals and companies could receive for investing in emerging biotechnology companies. “These tax credits are vitally important tools for nurturing growth among technology companies,” said GBC president Donald C. Fry. “They also … Continue reading →
Following is the text of a February 21 letter from GBC president Donald C. Fry to Senate Budget and Taxation Committee chairman Ullysses Currie voicing support for including $13.5 million in the FY 2007 capital budget for the proposed Center for Regenerative Research at the University of Maryland, Baltimore: Dear Senator Currie: Please allow this letter to serve as a statement of support for full funding for the proposed Center … Continue reading →
Four area biotech CEOs and a research center located at the University of Maryland School of Medicine today were honored by the Greater Baltimore Committee as winners of the region’s first bioscience award competition. Winners of the Greater Baltimore Region Bioscience Awards are: Entrepreneurial Spirit: Dr. Ginette Serrero, CEO, A&G Pharmaceutical, Inc., Columbia, Maryland. Serrero transformed her research on a new biomarker for breast cancer into a company that is … Continue reading →
Thirty-one nominees will vie for awards in four categories at the Greater Baltimore Committee’s first Annual Greater Baltimore Region Bioscience Awards, which will be presented on February 21 during 8 a.m. breakfast ceremonies in the GBC Board Room. Supporting the development of the emerging bioscience industry in the Baltimore region is one of the GBC’s top long-term priorities. As part of this effort, the awards program was established to recognize … Continue reading →
The Greater Baltimore Committee is urging state lawmakers to create a tax credit for businesses that locate at research parks affiliated with one of Maryland’s higher education institutions. Legislation that would create the tax credit, SB 739, has been filed by Senator Nathaniel J. McFadden, D-Baltimore City, and is before the Senate Budget and Taxation Committee. The bill would award a state income tax credit to companies moving into an … Continue reading →
Enactment of more aggressive tax credit programs and other funding to nurture the growth of life sciences and technology businesses are among the Greater Baltimore Committee’s top legislative priorities for the 2006 General Assembly session. The GBC will also work to oppose legislation that could inhibit the state’s use of eminent domain to acquire land for economic development purposes. The region’s most prominent organization of business and civic leaders, the … Continue reading →